Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

Market Cap	6.16B +54.5%
Revenue (ttm)	924.04M +18.8%
Net Income	79.70M +12.7%
EPS	0.18 +47.9%
Shares Out	499.27M
PE Ratio	67.80
Forward PE	42.55
Dividend	0.05 (0.41%)
Ex-Dividend Date	Jul 25, 2025

Volume	16,371,188
Average Volume	49,564,011
Open	12.46
Previous Close	12.33
Day's Range	12.20 - 12.46
52-Week Range	6.86 - 15.21
Beta	2.08
RSI	50.96
Earnings Date	Mar 24, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company provides cough and phlegm, kidney, anti-infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,341
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002728

Financial Performance

In 2024, SHE:002728's revenue was 687.79 million, a decrease of -35.55% compared to the previous year's 1.07 billion. Earnings were 20.50 million, a decrease of -91.90%.